Journal Guide

Contemporary Oncology is a journal aimed at oncologists, oncological surgeons, hematologists and radiologists.Journal published under the patronage of Stowarzyszenia na Rzecz Walki z Rakiem „Geny Zycia” (Poznan) and Fundacji Onkologii Doswiadczalnej i Klinicznej (Warsaw).

Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.

This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of breast cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention, systemic therapy, and translational research. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided. 

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of colorectal cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention and early detection, current and emerging therapeutic approaches, and molecular epidemiology. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

Current Oncology Reports provides in-depth review articles contributed by international experts on the most significant developments in the field.  By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal serves all those involved in the diagnosis, treatment, management, and prevention of cancer.

Current Opinion in HIV and AIDS offers full and complete coverage enabling clinicians and researchers to keep up-to-date with the vast amount of information published in the field. Insightful editorials and on-the-mark invited reviews bring readers up-to-speed on key subjects such as the T-cell in HIV infection and disease, reservoirs, host factors, HIV vaccines, antiretroviral therapy and clinical trial design.Website: www.co-hivandaids.com.

Current Opinion in Oncology Online provides a powerful, broad-based perspective on the most important advances in the field from throughout the world literature. Reader-friendly, the journal features renowned guest editors focusing exclusively on two topics each issue. Bimonthly, every issue of Current Opinion in Oncology delivers unvarnished, expert assessments of developments from the previous year. Insightful editorials and on-the-mark invited reviews cover key subjects such as endocrine tumors; melanoma and other skin neoplasms; the genitourinary system; supportive care; cancer in AIDS; and the breast--some 18 or more items in all of major relevance. All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is 'Current World Literature', an exceptionally thorough bibliography culled from the top 100 journals in the field.Website: www.co-oncology.com.

This reader-friendly, broad-based resource empowers those working in the fields of supportive and palliative care to put to good use vital clinical and research advances from throughout the world. The journal provides easy access to the very best thinking of the best minds in this dynamic, burgeoning field. Each quarterly issue features distinguished guest editors who focus exclusively on topics in their specialty. The journal delivers unvarnished, expert assessments of developments from the previous year8212;overviews found nowhere else. Insightful editorials and on-the-mark invited reviews bring readers up to speed on key subjects such as pain, gastrointestinal symptoms, psychological and cognitive problems, respiratory problems, renal and urological problems, bone and haematological problems, end-of-life management, cardiac and circulatory problems, cachexia, nutrition and hydration, HIV and other infections, quality of life, economics and ethics.All reviews are supplemented with an indispensable section, References and Recommended Reading. At the back of each volume is Current World Literature, an exceptionally thorough bibliography culled from the top 100 journals in the field. Website: www.co-supportiveandpalliativecare.com.

Each bimonthly issue of Current Problems in Cancer presents a single-topic, in-depth discussion, usually focused on the integrated management of a particular type of cancer or on a problem faced in a wide variety of malignancies. Issues may explore a particular category of drugs, an emerging interventional technique, or rehabilitation/reconstruction. Extensive bibliographies allow readers to easily locate additional information on related topics. Current Problems in Cancer serves the wide spectrum of physicians who treat patients with neoplastic disease.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.If you require any further information or help, please visit our support pages: http://support.elsevier.com

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on the most significant developments in the field.  By providing clear, insightful, balanced review articles that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the treatment of cancer.

‘Current Urology’ is an international peer-reviewed journal providing practical, timely, and state-of-the-art contributions on clinical research and experience in urology.

Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.The journal's scope includes research in:Stem cell processing and transplantationCell-based therapies of malignant and non-malignant blood diseasesCancerStem cell plasticityAutoimmune diseasesImmunotherapyCongenital disordersNovel molecular therapiesGene therapyMicrovesicle biology and therapeutic application

Zielsetzung der Zeitschrift
Der Onkologe behandelt praxisnah Fragen zu Diagnose und Therapie onkologischer Er­krankungen. Besondere Berücksichtigung finden dabei die onkologisch arbeitenden Fachrichtungen Innere Medizin, Radiologie und Chirurgie. Die interdisziplinäre Zeitschrift richtet sich an onkologisch tätige Ärzte in Praxis und Klinik.
Umfassende Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei evidenzbasiertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit – der Leser erhält konkrete Handlungsempfehlungen. Die Schwerpunktthemen werden von einem unabhängigen Herausgeberboard geplant. Ausgewiesene Experten verfassen anschließend die aufeinander abgestimmten Beiträge.
Beiträge der Rubrik „CME Zertifizierte Fortbildung“ bieten gesicherte Ergebnisse wissenschaftlicher Forschung und machen ärztliche Erfahrung für die tägliche Praxis nutzbar. Nach Lektüre der Beiträge kann der